3 of the Safest Ultra-High-Yield Dividend Stocks on the Planet to Buy Now
These high-octane dividend stocks, with yields ranging from 7.7% to 10%, can really pad investors' pocketbooks.
These high-octane dividend stocks, with yields ranging from 7.7% to 10%, can really pad investors' pocketbooks.
Energy Transfer LP (ET) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Right now, the average price for a loaf of bread is, approximately, $1.87. Under a new law proposed by House Republicans, that price would go up to more than $2.50. This would be the result of the Fair Tax Act, … Continue reading → The post Congress to Vote on Whether to Abolish the IRS and Introduce One National Tax Rate appeared first on SmartAsset Blog.
Elon Musk is still a risk to Tesla, warns one top analyst.
Yahoo Finance’s Jared Blikre joins the Live show to break down Intel’s latest earnings report.
Yahoo Finance’s Ines Ferre joins the Live show to discuss the White House’s take on Chevron’s buyback program.
Microsoft founder and billionaire turned philanthropist Bill Gates recently laid to rest the long-time conspiracy theory that he owns some 80% of all U.S. farmland in his 11th appearance in an “Ask Me Anything” (AMA) session on Reddit. What Happened: Gates, answering dozens of questions over the course of a few hours during the AMA, including: “Why are you buying up so much farmland, do you think this is a problem with billionaire wealth and how much you can disproportionally acquire?” In respon
Berkshire Hathaway CEO Warren Buffett is widely considered one of the best stock pickers of all time, and for good reason. Here are three top Buffett stocks that could make you richer in 2023 and beyond. Ally Financial (NYSE: ALLY) is an automotive-oriented online bank.
My wife and I are 70 years old. We've paid off everything, including the house. Between my pension of $29,000 and Social Security, we're getting a gross of $99,000 a year in income, which is more than enough. Our current … Continue reading → The post Ask an Advisor: We Are 70 Years Old, Have $99K in Retirement Income, a $1.4M IRA and Other Investments. Is It Too Late to Convert to a Roth? appeared first on SmartAsset Blog.
Novavax Inc said on Thursday it would require six months to produce a COVID-19 vaccine designed to match whichever coronavirus variants are circulating for an annual immunization program each fall season in the United States. The company suggested that the U.S. Food and Drug Administration select the prevalent variant of coronavirus in the first quarter each year, similar to the model employed to choose the composition for annual flu shots. The FDA in documents released on Monday proposed June for deciding on an annual COVID shot's make-up.
Sirius XM (SIRI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chevron will launch a massive $75 billion share buyback and raise its dividend, the Dow Jones energy giant announced late Wednesday. The news comes ahead of fourth-quarter earnings due on Friday. Chevron stock advanced Thursday.
In this article, we discuss 15 most undervalued quality stocks to buy according to hedge funds. If you want to see more stocks in this selection, 5 Most Undervalued Quality Stocks To Buy According To Hedge Funds. Quality stocks usually have little debt, steady earnings, regular growth in assets, and effective leadership. Investors can identify […]
After being shunned for most of 2022, the mortgage real estate investment trust (REIT) sector regained some popularity as investors sensed the Federal Reserve's tightening cycle is wrapping up, which will remove a major headwind for the sector. The two biggest mortgage REITs, AGNC Investment (NASDAQ: AGNC) and Annaly Capital Management (NYSE: NLY), have mounted quite the rally over the past several months. The idea is that rental income will cover the interest costs on the debt the REIT used to finance the property.
Apple (AAPL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2023 is shaping up to be a rough year for Americans and Barry Sternlicht has a timeline for when a recession might reach our shores.
Stocks moving in after hours: Intel, Hasbro, Visa
Today we will run through one way of estimating the intrinsic value of ZIM Integrated Shipping Services Ltd. ( NYSE:ZIM...
The crypto exchange wants to question its founder’s family as it seeks to locate allegedly misappropriated funds
Intel Corp. shares dropped more than 9% in the extended session Thursday after the chip maker reported a big miss for the fourth quarter, forecast a loss for the first quarter, said the data-center market was contracting and that inventory digestion will gnaw at margins.
Shareholders of Catalyst Pharmaceuticals (NASDAQ: CPRX) got a nasty shock on Jan. 23 when the company reported that a competitor, Teva Pharmaceutical Industries (NYSE: TEVA), was planning to make a generic version of its only marketed drug, Firdapse. With Catalyst's shares falling 30% in a day before slightly recovering, it's clear that the market is interpreting Teva's actions as severely threatening, and it's reasonable for investors to wonder if it's time to start looking for the door. First, let's take a moment to understand what Firdapse means for Catalyst Pharmaceuticals.